1974
DOI: 10.1093/ajhp/31.1.79
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a patient medication profile based on the use of duplicate labels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1978
1978
1978
1978

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In SA, for example, the first two items have been combined in Schedule 3 of the Medicines Control Act [60] , in which prescription medication for certain chronic conditions may be repeated to a maximum period of 6 months at the pharmacist's discretion. The third element is based on the emergence of biopharmaceutics as a precise science [61], The fourth need not be as costly as might be imagined as inexpensive duplicate label systems have already appeared [62] [63] . They do not require skilled personnel to maintain.…”
Section: Monitoring Drug Therapymentioning
confidence: 99%
“…In SA, for example, the first two items have been combined in Schedule 3 of the Medicines Control Act [60] , in which prescription medication for certain chronic conditions may be repeated to a maximum period of 6 months at the pharmacist's discretion. The third element is based on the emergence of biopharmaceutics as a precise science [61], The fourth need not be as costly as might be imagined as inexpensive duplicate label systems have already appeared [62] [63] . They do not require skilled personnel to maintain.…”
Section: Monitoring Drug Therapymentioning
confidence: 99%